Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: A Multicenter Phase 2 Clinical Trial of Pembrolizumab in Refractory Metastatic Anal Cancer
Brief Summary:
This research study is studying a targeted therapy as a possible treatment for advanced anal cancer.
The following intervention will be involved in this study:
-Pembrolizumab